|
Name |
Streptomethiocin B
|
Molecular Formula | C20H22N4O8S2 | |
IUPAC Name* |
(2R)-3-[[(2R)-2-carboxy-2-[(3-hydroxypyridine-2-carbonyl)amino]propyl]disulfanyl]-2-[(3-hydroxypyridine-2-carbonyl)amino]-2-methylpropanoic acid
|
|
SMILES |
C[C@](CSSC[C@@](C)(C(=O)O)NC(=O)C1=C(C=CC=N1)O)(C(=O)O)NC(=O)C2=C(C=CC=N2)O
|
|
InChI |
InChI=1S/C20H22N4O8S2/c1-19(17(29)30,23-15(27)13-11(25)5-3-7-21-13)9-33-34-10-20(2,18(31)32)24-16(28)14-12(26)6-4-8-22-14/h3-8,25-26H,9-10H2,1-2H3,(H,23,27)(H,24,28)(H,29,30)(H,31,32)/t19-,20-/m0/s1
|
|
InChIKey |
ZCTPMLZHDHDIAO-PMACEKPBSA-N
|
|
Synonyms |
Streptomethiocin B
|
|
CAS | NA | |
PubChem CID | 156582645 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 510.5 | ALogp: | 1.4 |
HBD: | 6 | HBA: | 12 |
Rotatable Bonds: | 11 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 250.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 34 | QED Weighted: | 0.189 |
Caco-2 Permeability: | -6.157 | MDCK Permeability: | 0.00000469 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.165 |
Human Intestinal Absorption (HIA): | 0.023 | 20% Bioavailability (F20%): | 0.07 |
30% Bioavailability (F30%): | 0.008 |
Blood-Brain-Barrier Penetration (BBB): | 0.042 | Plasma Protein Binding (PPB): | 75.81% |
Volume Distribution (VD): | 0.171 | Fu: | 38.77% |
CYP1A2-inhibitor: | 0.004 | CYP1A2-substrate: | 0.052 |
CYP2C19-inhibitor: | 0.015 | CYP2C19-substrate: | 0.036 |
CYP2C9-inhibitor: | 0.09 | CYP2C9-substrate: | 0.71 |
CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.082 |
CYP3A4-inhibitor: | 0.042 | CYP3A4-substrate: | 0.017 |
Clearance (CL): | 1.325 | Half-life (T1/2): | 0.869 |
hERG Blockers: | 0.01 | Human Hepatotoxicity (H-HT): | 0.183 |
Drug-inuced Liver Injury (DILI): | 0.982 | AMES Toxicity: | 0.011 |
Rat Oral Acute Toxicity: | 0.007 | Maximum Recommended Daily Dose: | 0.024 |
Skin Sensitization: | 0.119 | Carcinogencity: | 0.051 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.059 |
Respiratory Toxicity: | 0.047 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004416 | 0.663 | D0P7JZ | 0.252 | ||||
ENC004414 | 0.325 | D0A6KR | 0.242 | ||||
ENC002976 | 0.273 | D0SH3I | 0.232 | ||||
ENC003644 | 0.270 | D05ZGQ | 0.230 | ||||
ENC002362 | 0.254 | D00WCX | 0.229 | ||||
ENC003620 | 0.252 | D0Q9JT | 0.228 | ||||
ENC005677 | 0.248 | D05QHL | 0.228 | ||||
ENC004263 | 0.247 | D0I1FQ | 0.226 | ||||
ENC004239 | 0.246 | D00KRE | 0.226 | ||||
ENC004765 | 0.244 | D0BA6T | 0.224 |